Highlights
1 patent
About
Biosimilar and Generic Drug Development
InSight Biopharmaceutical develops biosimilar drugs with properties virtually identical to other previously approved drugs. The company has focused on introducing biosimilars to major markets through strategic alliances. Insight Biopharmaceutical's portfolio consists of a wide range of biosimilars in the fields of fertility, oncology, neurology, and rheumatology. In 2017, the company's intellectual property and assets were sold to Estonian company PharmaEstica Manufacturing and its Israeli partner. InSight is conducting the acquisition through InSight Innovation Ltd, a subsidiary it established specifically for the deal.
Identity
| Name | InSight Biopharmaceutical |
|---|---|
| Slug | insight-biopharmaceuticals |
| Type / kind | startup |
| Crunchbase ID | insight-biopharmaceutical |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL7sxKoIDA |
Status
| Status | inactive |
|---|---|
| Status reason | Acquired (Inactive) by PharmaEstica Manufacturing on Jul 2017 - closed due to acquisition |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Rehovot |
| HQ address | HaMada Street 12, Rehovot, Israel |
Web & social
| Website | http://www.insight.co.il |
|---|---|
| https://www.linkedin.com/company/1227626 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
oncologyfertilityneurology
Funding
| Total raised | — |
|---|---|
| Current stage | Acquired |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}